ACELYRIN, INC. (SLRN)
(Delayed Data from NSDQ)
$4.98 USD
+0.07 (1.43%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $4.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Income Statements
Fiscal Year end for ACELYRIN, INC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | NA | NA |
Cost Of Goods | 0 | 0 | 0 | NA | NA |
Gross Profit | 0 | 0 | 0 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 422 | 69 | 42 | 0 | 0 |
Income After Depreciation & Amortization | -422 | -69 | -42 | 0 | 0 |
Non-Operating Income | 40 | 4 | 0 | NA | NA |
Interest Expense | 0 | 0 | 0 | NA | NA |
Pretax Income | -382 | -65 | -42 | NA | NA |
Income Taxes | 0 | 0 | 0 | NA | NA |
Minority Interest | 0 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -382 | -65 | -42 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -382 | -65 | -42 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -432 | -69 | -42 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | -10 | 0 | 0 | NA | NA |
Income After Depreciation & Amortization | -422 | -69 | -42 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 70.25 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -5.43 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -5.43 | -41.59 | NA | NA | NA |
Fiscal Year end for ACELYRIN, INC falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 93.02 | 82.77 | 105.11 | 94.42 | 42.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | -93.02 | -82.77 | -105.11 | -94.42 | -42.70 |
Non-Operating Income | 7.35 | 47.80 | 9.90 | 10.48 | 16.66 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -85.67 | -34.97 | -95.21 | -83.94 | -26.04 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -85.67 | -34.97 | -95.21 | -83.94 | -26.04 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -85.67 | -34.97 | -95.21 | -83.94 | -26.04 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 99.16 | 97.91 | 70.25 | 96.87 | 65.21 |
Diluted EPS Before Non-Recurring Items | -0.86 | -0.36 | -0.75 | -0.87 | -0.56 |
Diluted Net EPS (GAAP) | -0.86 | -0.36 | 4.45 | -0.87 | -0.40 |